Thymoma: Current medical and surgical management

Seminars in Neurology

Volumn 24, Issue 1, 2004, Pages 63-73

  Kesler, Kenneth A ^a,c   Wright, Cameron D ^d   Loehrer, Patrick J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kenneth Wiseman Dept of Medicine   (United States)

^c Department of Surgery   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Chemotherapy; Myasthenia gravis; Surgery; Thymoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; VINCRISTINE;

ADVANCED CANCER; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; LONG TERM CARE; METASTASIS; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; REVIEW; THORAX RADIOGRAPHY; THORAX SURGERY; THYMOMA;

CISPLATIN; COMBINED MODALITY THERAPY; HUMANS; SURVIVAL RATE; THYMECTOMY; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3042588701     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-829588     Document Type: Review

References (66)

1. Shields TW. Primary lesions of the mediastinum and their investigation and treatment. In: Shields TW, ed. General Thoracic Surgery, 4th ed. Baltimore, MD: Williams and Wilkins Publishers; 1994:1724-1796
2. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003;105:546-551
3. Wilkins EW. Thymoma. In: Pearson FG, Deslauriers J, Ginsberg RJ, et al, eds. Thoracic Surgery. New York: Churchill Livingstone Publishers; 1995:1419-1427
4. Morgenthaler TI, Brown LR, Colby TV, et al. Thymoma. Mayo Clin Proc 1993;68:1110-1123
5. Souadjian JV, Enriquez P, Silverstein MN, et al. The spectrum of diseases associated with thymoma: coincidence or syndrome? Arch Intern Med 1974;134:374-379
6. Voltz RD, Albrich WE, Nagele A, et al. Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology 1997;49:1454-1457
7. Gautel M, Lakey A, Barlow DP, et al. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 1993;43:1581-1585
8. Ballow M, O'Neil KM. Approach to the patient with recurrent infections. In: Middleton E, Reed CE, Ellis EF, et al, eds. Allergy: Principles and Practice, 5th ed. St. Louis, MO: Mosby Publishing; 1998:735-759
9. Bulkley GB, Bass KN, Stephenson R, et al. Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 1997;226:324-335
10. Cumming WJK, Hudgeson P. The role of plasmapheresis in preparing patients with myasthenia for thymectomy. Muscle Nerve 1986;9:S155-S158
11. Mulder DM. Extended transsternal thymectomy. In: Shields TW, ed. General Thoracic Surgery, 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins Publishers; 2000:2233-2237
12. Kesler KA, Rieger KM, Ganjoo KN, et al. Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery. J Thorac Cardiovasc Surg 1999;118:692-701
13. Kubota K, Yamada S, Kondo T, et al. PET imaging of primary mediastinal tumours. Br J Cancer 1996;73:882-886
14. Maggi G, Casadio C, Cavallo A, et al. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991;51:152-156
15. Morrissey B, Adams H, Gibbs AR, et al. Percutaneous needle biopsy of the mediastinum: review of 94 procedures. Thorax 1993;48:632-637
16. Bernatz PE, Harrison EG, Clagett OT. Thymoma: a clinicopathologic study. J West Soc Periodontol Periodontal Abstr 1961;42:424-444
17. Marino M, Muller-Hermelink HK. Thymoma and thymic carcinoma: relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 1985;407:119-149
18. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002;94:624-632
19. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features and survival in 200 cases. Cancer 1985;55:1074-1086
20. Pesamona E, Rendina EA, Veruta F, et al. The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases. Am J Clin Pathol 1990;93:190-195
21. Masaoka A, Mondem Y, Nakahara K, et al. Follow-up study of thymoma with special reference to their clinical stages. Cancer 1981;48:2485-2492
22. Masaoka A, Yamakawa Y, Niwa H, et al. Thymectomy and malignancy. Eur J Cardiothorac Surg 1994;8:251-253
23. Schneider PM, Fellbaum C, Fink U, et al. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol 1997;4:46-56
24. Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003;126:1134-1140
25. Port JL, Ginsberg RJ. Surgery for thymoma. Chest Surg Clin N Am 2001;11:421-437
26. Kaiser LR. Thymoma. The use of minimally invasive resection techniques. Chest Surg Clin N Am 1994;4:185-194
27. Roviaro G, Rebuffat C, Varonli F, et al. Videothoracoscopic excision of mediastinal masses: indications and techniques. Ann Thorac Surg 1994;58:1679-1684
28. Landreneau RJ, Dowling RD, Castillo WM, et al. Thoracoscopic resection of an anterior mediastinal tumor. Ann Thorac Surg 1992;54:142-144
29. Acuff TE, Mack MJ, Ryan WH, et al. Thoracoscopic thymoma resection. Ann Thorac Surg 1993;55:562-563
30. Curran WJ, Kornstein FJ, Brooks JJ, et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988;6:1722-1727
31. Pollack A, Komaki R, Cox JD, et al. Thymoma: treatment and prognosis. Int J Radiat Oncol Biol Physiol 1992;23:1037-1043
32. Ogawa K, Uno T, Toita T, et al. Postoperative radiotherapy for patients with completely resected thymoma. Cancer 2002;94:1405-1413
33. Haniuda M, Morimoto M, Nishimura H, et al. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg 1992;54:311-315
34. Mangi AA, Wright CD, Allan JS, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 2002;74:1033-1037
35. Singhal S, Shrager JB, Rosenthal DI, et al. Comparison of stages: thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 2003;76:1635-1642
36. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-885
37. Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol 1999;17:2280-2289
38. Macchiarini P, Chella A, Ducci F, et al. Neoadjuvant chemotherapy, surgery and postoperative radiation therapy for invasive thymoma. Cancer 1991;68:706-713
39. Berruti A, Borasio P, Gerbino A, et al. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience. Br J Cancer 1999;81:841-845
40. Rea F, Sartori F, Loy M, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993;106:543-549
41. Shin DM, Walsh GL, Komake R, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998;129:100-104
42. Kim ES, Putnam JB, Komaki R, et al. A phase II study of a multidisciplinary approach with induction chemotherapy followed by surgical resection, radiation therapy and consolidation chemotherapy for unresectable malignant thymomas: final report. Proc Am Soc Clin Oncol 2001;20:310A
43. Loehrer PJ, Chen M, Kim K, et al. Cisplatin, doxorubicin and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 1997;15:3093-3099
44. Loehrer PJ, Kim KM, Aisner SC, et al. Cisplatin plus doxorubicin plus cydophosphamide in metastatic or recurrent thymoma: final results of an Intergroup trial. J Clin Oncol 1994;12:1164-1168
45. Yagi K, Hirata T, Fukuse T, et al. Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 1996;61:521-524
46. Akaogi E, Ohara K, Mitsui K, et al. Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels. J Surg Oncol 1996;63:17-22
47. Okumura M, Miyoshi S, Takeuchi Y, et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 1999;117:605-613
48. Nakahara K, Ohno K, Hashimoto J, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988;95:1041-1047
49. Kohman LJ. Controversies in the management of malignant thymoma. Chest 1997;112:296S-300S
50. Regnard JF, Zinzindohoue F, Magdeleinat P, et al. Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997;64:1593-1598
51. Kirschner PA. Reoperation for thymoma: report of 23 cases. Ann Thorac Surg 1990;49:550-555
52. Park HS, Shin DM, Lee JS, et al. Thymoma. A retrospective study of 87 cases. Cancer 1994;73:2491-2498
53. Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy for invasive thymoma. A 13-year experience. Cancer 1991;68:30-33
54. Giaccone G, Ardizzoni A, Kirkpatrick A, et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1996;14:814-820
55. Lin K, Nguyen BD, Ettinger DS, et al. Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma. Clin Nucl Med 1999;24:24-28
56. Loehrer PJ, Jiroutek M, Aisner S, et al. Combined etoposide, ifosfamide and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 2001;91:2010-2015
57. Park HS, Shin DM, Lee JS, et al. Thymoma: a retrospective study of 87 cases. Cancer 1994;73:2491-2498
58. Budde JM, Morris CD, Gal AA, et al. Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg 2001;72:197-202
59. Maggi G, Casadio C, Cavallo A, et al. Thymectomy in myasthenia gravis: results of 662 cases operated upon in 15 years. Eur J Cardiothorac Surg 1989;3:504-511
60. de Perrot M, Liu J, Bril V, et al. Prognostic significance of thymomas in patients with myasthenia gravis. Ann Thorac Surg 2002;74:1658-1662
61. Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996;112:376-384
62. Wilkins EW Jr, Grillo HC, Scannell JG, et al. J. Maxwell Chamberlain Memorial Paper. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 1991;51:888-892
63. Evoli A, Minisci C, Di Schino C, et al. Thymoma in patients with myasthenia gravis: characteristics and long-term outcome. Neurology 2002;59:1844-1850
64. Souadjian JV, Enriquez P, Siverstein MN, Pepin JM. The spectrum of diseases associated with thymoma: coincidence or syndrome? Arch Intern Med 1974;134:374-379
65. Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 1999;230:562-572
66. Welsh JS, Wilkins KB, Green R, et al. Association between thymoma and second neoplasms. JAMA 2000;283:1142-1143